Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Jens Bjerre"'
Autor:
Mariasanta Napolitano, Muriel Giansily-Blaizot, Alberto Dolce, Jean F. Schved, Guenter Auerswald, Jørgen Ingerslev, Jens Bjerre, Carmen Altisent, Pimlak Charoenkwan, Lisa Michaels, Ampaiwan Chuansumrit, Giovanni Di Minno, Ümran Caliskan, Guglielmo Mariani
Publikováno v:
Haematologica, Vol 98, Iss 4 (2013)
Because of the very short half-life of factor VII, prophylaxis in factor VII deficiency is considered a difficult endeavor. The clinical efficacy and safety of prophylactic regimens, and indications for their use, were evaluated in factor VII-deficie
Externí odkaz:
https://doaj.org/article/2202d40ca6cf499d8622c5ce03237f5b
Autor:
Gorman, Colum A *, Zimmerman, Bruce R, Smith, Steven A, Dinneen, Sean F, Knudsen, Jens Bjerre, Holm, DeAnne, Jorgensen, Barbara, Bjornsen, Susan, Planet, Kim, Hanson, Penny, Rizza, Robert A
Publikováno v:
In Computer Methods and Programs in Biomedicine 2000 62(2):127-140
Autor:
Alberto Dolce, Guglielmo Mariani, Jørgen Ingerslev, Jens Bjerre Knudsen, Jean François Schved, Sergio Siragusa, Günter Auerswald, M. Napolitano, Angelika Batorova
Publikováno v:
British Journal of Haematology. 152:340-346
Excessive bleeding represents a major complication of surgical interventions and its control is especially relevant in patients with Congenital Bleeding Disorders (CBD). In factor VII (FVII) deficiency, scanty data on surgery is available to guide tr
Publikováno v:
Blood Coagulation & Fibrinolysis. 20:488-493
The success of a treatment in haemophilia patients experiencing a bleeding episode is very difficult to define. A variety of efficacy assessment tools have been developed in an effort to better assess when haemostasis has been achieved. These assessm
Autor:
Anne Mette Nøhr, Jens Bjerre, Hanne Nedergaard, Morten Wagner Kristiansen, Susanne Vestergaard, Oktavia Jonasdottir
Publikováno v:
Current Medical Research and Opinion. 25:2699-2702
To investigate effects of air transport and X-ray radiation exposure through airport security of a new room temperature-stable rFVIIa formulation (NovoSeven/NovoSeven RT, Novo Nordisk A/S, Bagsvaerd, Denmark) lyophilized using in vitro study methodol
Autor:
Anna B. Schönwandt, Michael Bech Jensen, Preben Þstfeldt, Tina Norsell, Hanne Nedergaard, Per B. Þstergaard, Jens Bjerre, Britt Petersson
Publikováno v:
Clinical Therapeutics. 30:917-923
Background: Recombinant activated factor VIIa (rFVIIa) is indicated for on-demand treatment of bleeding and the prevention and treatment of surgical bleeding in patients with hemophilia A or B who have antibodies to coagulation factors VIII or IX. Th
Publikováno v:
Transfusion and Apheresis Science. 38:25-32
Children and adolescents comprise a significant proportion of the hemophilia population, including those patients who have developed inhibitors to factor VIII or FIX. We examine the use of rFVIIa for the treatment of bleeding episodes and the prevent
Autor:
Yves Laurian, Zvika S. Abrams, Man-Chiu Poon, Jens Bjerre Knudsen, Giovanni Di Minno, Rainer B. Zotz
Publikováno v:
Seminars in Hematology. 43:S33-S36
Glanzmann's thrombasthenia (GT) is a rare congenital bleeding disorder caused by deficiency or dysfunction of platelet surface glycoprotein (GP) IIb/IIIa receptor. Platelet transfusion is the standard treatment for bleeding that remains non-responsiv
Autor:
Barbara Jorgensen, Robert A. Rizza, Colum A. Gorman, Penny L. Hanson, Bruce R. Zimmerman, Sean F. Dinneen, Steven A. Smith, DeAnne Holm, Susan S. Bjornsen, Kim Planet, Jens Bjerre Knudsen
Publikováno v:
Computer Methods and Programs in Biomedicine. 62:127-140
Diabetes electronic management system (DEMS) is a component-based client/server application, written in Visual C++ and Visual Basic, with the database server running Sybase System 11. DEMS is built entirely with a combination of dynamic link librarie
Autor:
Ampaiwan Chuansumrit, Jens Bjerre, Lisa Michaels, M. Napolitano, Pimlak Charoenkwan, G. Mariani, Muriel Giansily-Blaizot, Umran Caliskan, Guenter Auerswald, Carmen Altisent, Jørgen Ingerslev, Giovanni Di Minno, Alberto Dolce, Jean-François Schved
WOS: 000319897700018
PubMed: 23403322
Because of the very short half-life of factor VII, prophylaxis in factor VII deficiency is considered a difficult endeavor. The clinical efficacy and safety of prophylactic regimens, and indications for
PubMed: 23403322
Because of the very short half-life of factor VII, prophylaxis in factor VII deficiency is considered a difficult endeavor. The clinical efficacy and safety of prophylactic regimens, and indications for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d23de6ffa9bf88474de895899830478c
https://hdl.handle.net/20.500.12395/29755
https://hdl.handle.net/20.500.12395/29755